The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world retrospective study of oral versus intravenous HMA-induced toxicity in MDS and AML treatment.
 
Julia Palecki
No Relationships to Disclose
 
Andrew Bernstein
No Relationships to Disclose
 
Leland F. Damron
No Relationships to Disclose
 
Misung Yi
No Relationships to Disclose
 
Lindsay Wilde
Research Funding - Gilead Sciences (Inst); Protagonist Therapeutics (Inst)
 
Gina Keiffer
Honoraria - Astellas Pharma
Research Funding - Abbvie (Inst); Prelude Therapeutics (Inst); Schrodiger (Inst); Sumitomo Pharma Oncology (Inst)
 
Chetan Jeurkar
No Relationships to Disclose
 
Margaret T. Kasner
Consulting or Advisory Role - Abbvie/Genentech (I); Bayer (I); Daiichi Sankyo; DAVA Pharmaceuticals; GORE (I); Jazz Pharmaceuticals; Otsuka
Research Funding - Astellas Pharma (Inst); Bayer (I); Biogenerix (I); Bristol Myers Squibb Foundation (I); Daiichi Sankyo (Inst); Gentech (Inst); Gilead Sciences (Inst); GORE (I); Janssen (I); otsuka (Inst); Pfizer (Inst)